Ticker archive · $RFL

$RFL Filing Signals & Market Reactions

Delayed, SEO-crawlable recaps of AI-scored catalysts for $RFL — including observed post-filing price moves. Live streaming stays exclusive to VIP.

? All delayed signals

$RFL

$RFL – Rafael Holdings Reports FY2026 Results, NDA Submission Amid Cash Decline

Rafael Holdings, Inc.

2026-10-29 00:00:00 UTC · SEC_8K · All $RFL

?? Negative AI Sentiment (-2.0 / 10)

Cash and cash equivalents decreased from $52.8M to $22.1M year-over-year.
Cyclo Therapeutics submitted a New Drug Application (NDA) for remibetadex on October 28, 2026.
Operating loss remains elevated at roughly $9.7M for the quarter on negligible revenues.

Unlock Live VIP Terminal & Telegram – €10/mo Original filing ?